Aspirin, even at low dose, carries risk of gastrointestinal bleeding

November 09, 2000

Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

Long term use of aspirin to prevent heart problems carries an increased risk of gastrointestinal bleeding, according to a study in this week's BMJ. Furthermore, no evidence exists that reducing the dose or using expensive "modified release" formulations of aspirin would reduce the likelihood of bleeding.

Researchers at the Radcliffe Infirmary in Oxford analysed 24 previous studies of aspirin, involving almost 66,000 patients, to establish the risk of gastrointestinal bleeding from long term treatment with aspirin. There were two main results. Firstly, bleeding occurred, on average, in 2.5% of patients taking aspirin compared with 1.4% who were not; this difference was statistically significant. Secondly, there was no evidence to suggest that switching to a low dose or modified release formulation of aspirin would reduce the problem.

Given the widespread use of aspirin for the prevention of heart problems, these findings have important implications for everyday practice, say the authors. Patients and doctors need to consider the trade-off between the benefits and harms of long term treatment with aspirin, they conclude.

In an accompanying editorial, Martin Tramr argues that we do not know who should be given what dose of aspirin and for how long. Physicians have been treating their patients with low dose aspirin on the understanding that they did more good than harm, yet innovative research is needed to estimate rare events with confidence, he concludes.
-end-
Contacts:

[Paper]: Yoon Kong Loke, University of Oxford, Radcliffe Infirmary, Oxford, UK
Tel: +44 (0)1865 241 091 or switchboard +44 (0)1865 741 166 (bleep number 1169)
Fax: +44 (0)1865 791 712 Email: yoon.loke@clinpharm.ox.ac.uk

[Editorial]: Martin Tramr, Division of Anaesthesiology, Geneva University Hospitals, Switzerland
Tel: +41 22 382 7403 (Not available on Thursday 9 November)
Fax: +41 22 382 7511

BMJ

Related Aspirin Articles from Brightsurf:

An aspirin a day keeps the bowel doctor away
A regular dose of aspirin to reduce the risk of inherited bowel cancer lasts at least 10 years after stopping treatment, research has revealed.

What are the risks and benefits of low-dose aspirin?
Low-dose aspirin significantly lowers cardiovascular disease risk but increases the risk of bleeding, according to a review published in the British Journal of Clinical Pharmacology.

Benefit seen for ticagrelor alone, without aspirin, in patients with ACS
The research was presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).

Study: An aspirin a day does not keep dementia at bay
Taking a low-dose aspirin once a day does not reduce the risk of thinking and memory problems caused by mild cognitive impairment or probable Alzheimer's disease, nor does it slow the rate of cognitive decline, according to a large study published in the March 25, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Aspirin's health benefits under scrutiny
Taking a baby aspirin every day to prevent a heart attack or stroke should no longer be recommended to patients who haven't already experienced one of these events.

Aspirin may no longer be effective as cardiovascular treatment
A new paper in Family Practice, published by Oxford University Press, found that the widespread use of statins and cancer screening technology may have altered the benefits of aspirin use.

Migraine headaches? Consider aspirin for treatment and prevention
Evidence from 13 randomized trials of the treatment of migraine in 4,222 patients and tens of thousands of patients in prevention of recurrent attacks supports the use of high dose aspirin from 900 to 1,300 milligrams to treat acute migraine as well as low dose daily aspirin from 81 to 325 milligrams to prevent recurrent attacks.

Aspirin use after biliary tract cancer diagnosis
Researchers in this observational study examined if aspirin use after a diagnosis of a biliary tract cancer, which includes gallbladder cancer, was associated with reduced risk of death among nearly 3,000 patients.

Aspirin may prevent air pollution harms
A new study is the first to report evidence that nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin may lessen the adverse effects of air pollution exposure on lung function.

Aspirin should not be recommended for healthy people over 70
Low-dose aspirin does not prolong disability-free survival of healthy people over 70, even in those at the highest risk of cardiovascular disease.

Read More: Aspirin News and Aspirin Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.